Evidence for novel cannabinoid receptors

Pharmacology and Therapeutics

Volumn 106, Issue 2, 2005, Pages 133-145

  Begg, Malcolm ^a,b   Pacher, Pál ^a   Bátkai, Sándor ^a   Osei Hyiaman, Douglas ^a   Offertáler, László ^a   Fong, Ming Mo ^a   Liu, Jie ^a   Kunos, George ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Cannabinoid receptors; Endocannabinoids; Endothelium; Hippocampus; Vasodilation

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; BLOCKING AGENT; CALCITONIN; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; CAPSAZEPINE; CARBACHOL; CHARYBDOTOXIN; DEXANABINOL; ENDOCANNABINOID; G PROTEIN COUPLED RECEPTOR; IBERIOTOXIN; INDOMETACIN; KT 5823; LIPID; METHANANDAMIDE; N(G) NITROARGININE METHYL ESTER; O 1918; PROSTACYCLIN; RIMONABANT; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1; VASODILATOR AGENT;

DRUG EFFICACY; DRUG INHIBITION; DRUG POTENCY; HEMATOPOIETIC TISSUE; HIPPOCAMPUS; HUMAN; IMMUNITY; MESENTERY BLOOD FLOW; MOLECULAR BIOLOGY; MOLECULAR CLONING; NEUROTRANSMISSION; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASODILATATION;

EID: 18144385088     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2004.11.005     Document Type: Review

References (126)

1. M.D. Adams, J.T. Earnhardt, B.R. Martin, L.S. Harris, W.L. Dewey, and R.K. Razdan A cannabinoid with cardiovascular activity but no overt behavioral effects Experientia 33 1977 1204 1205
2. A. Al-Hayani, and S.N. Davies Cannabinoid receptor mediated inhibition of excitatory synaptic transmission is the rat hippocampal slice is developmentally regulated Br J Pharmacol 131 2000 663 665
3. A. Al-Hayani, K.N. Wease, R.A. Ross, R.G. Pertwee, and S.N. Davies The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice Neuropharmacology 41 2001 1000 1005
4. A. Ameri, A. Wilhelm, and T. Simmet Effects of endogenous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices Br J Pharmacol 126 1999 1831 1839
5. S. Bátkai, P. Pacher, Z. Járai, J.A. Wagner, and G. Kunos Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors Am J Physiol Heart Circ Physiol 287 2004 H595 H600
6. + current J Biol Chem 278 2003 46188 46194
7. T. Bisogno, D. Melsck, M.Y. Bobrov, N.M. Gretskaya, V.V. Bezuglov, and L. De Petrocellis N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo Biochem J 351 2000 817 824
8. A. Bonz, M. Laser, S. Kullmer, S. Kniesch, J. Babin-Ebell, and V. Popp Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle J Cardiovasc Pharmacol 41 2003 657 664
9. M. Bouaboula, D. Dussossoy, and P. Casellas Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses J Biol Chem 274 1999 20397 20405
10. M. Bouaboula, S. Perrachon, L. Milligan, X. Canat, M. Rinaldi-Carmona, and M. Portier A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions J Biol Chem 272 1997 22330 22339
11. M. Bouaboula, C. Poinot-Chazel, B. Bourrie, X. Canat, B. Calandra, and M. Rinaldi-Carmona Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 Biochem J 312 1995 637 641
12. C.S. Breivogel, G. Griffin, V. Di Marzo, and B.R. Martin Evidence for a new G protein-coupled receptor in mouse brain Mol Pharmacol 60 2001 155 163
13. N.E. Buckley, K.L. McCoy, E. Mezey, T. Bonner, A. Zimmer, and C.C. Felder Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor Eur J Pharmacol 396 2000 141 149
14. R.D. Bukoski, S. Bátkai, Z. Járai, Y. Wang, L. Offertáler, and W.F. Jackson CB(1) receptor antagonist SR141716A inhibits Ca(2+)-induced relaxation in CB(1) receptor-deficient mice Hypertension 39 2002 251 257
15. A. Calignano, G. La Rana, A. Giuffrida, and D. Piomelli Control of pain initiation by endogenous cannabinoids Nature 394 1998 277 281
16. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius The capsaicin receptor: a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
17. A.T. Chaytor, P.E.M. Martin, W.H. Evans, M.D. Randall, and T.M. Griffith The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication J Physiol (Lond) 520 1999 539 550
18. P. Consroe, R. Musty, J. Rein, W. Tillery, and R. Pertwee The perceived effects of smoked cannabis on patients with multiple sclerosis Eur Neurol 38 1997 44 48
19. P. Derkinderen, C. Ledent, M. Parmentier, and J.A. Girault Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus J Neurochem 77 2001 957 960
20. P. Derkinderen, M. Toutant, F. Burgaya, M. Le Bert, J.C. Siciliano, and V. de Franciscis Regulation of a neuronal form of focal adhesion kinase by anandamide Science 273 1996 1719 1722
21. P. Derkinderen, E. Valjent, M. Toutant, J.C. Corvol, H. Enslen, and C. Ledent Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus J Neurosci 23 2003 2371 2382
22. W.A. Devane, F.A. Dysarz III, M.R. Johnson, L.S. Melvin, and A.C. Howlett Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 1988 605 613
23. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, and G. Griffin Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
24. V. Di Marzo, T. Bisogno, D. Melck, R. Ross, H. Brockie, and L. Stevenson Interactions between synthetic vanilloids and the endogenous cannabinoids system FEBS Lett 436 1998 449 454
25. M. Duncan, P. Millns, D. Smart, J.E. Wright, D.A. Kendall, and V. Ralevic Noladin ether, a putative endocannabionoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 Gi/o linked receptor Br J Pharmacol 142 2004 509 518
26. C.C. Felder, K.E. Joyce, E.M. Briley, J. Mansouri, K. Mackie, and O. Blond Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors Mol Pharmacol 48 1995 443 450
27. W.R. Ford, S.A. Honan, R. White, and C.R. Hiley Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilator responses in rat isolated hearts Br J Pharmacol 135 2002 1191 1198
28. A. Franklin, and N. Stella Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol- sensitive receptors Eur J Pharmacol 474 2004 195 198
29. A. Franklin, S. Parmentier-Batteur, L. Walter, D.A. Greenberg, and N. Stella Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility J Neurosci 23 2003 7767 7775
30. E. Fride, A. Foox, E. Rosenberg, M. Faigenboim, V. Cohen, and L. Barda Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor Eur J Pharmacol 461 2003 27 34
31. S.J. Gatley, R. Lan, B. Pyatt, A.N. Gifford, N.D. Volkow, and A. Makriyannis Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors Life Sci 61 1997 PL191 PL197
32. 2+ channel current Am J Physiol 266 1999 H2085 H2093
33. C.M. Gerard, C. Mollereau, G. Vassart, and M. Parmentier Molecular cloning of a human cannabinoid receptor which is also expressed in testis Biochem J 279 1991 129 134
34. M. Glass, and J.K. Northup Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors Mol Pharmacol 56 1999 1362 1369
35. G. Godlewski, B. Malinowska, and E. Schlicker Presynaptic cannabinoid CB1 receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock Br J Pharmacol 142 2004 701 708
36. T. Gomez del Pulgar, G. Velasco, and M. Guzman The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt Biochem J 347 2000 369 373
37. J. Grainger, and G. Boachie-Ansah Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels Br J Pharmacol 134 2001 1003 1012
38. G. Griffin, S.R. Fernando, R.A. Ross, N.G. McKay, M.l. Ashford, and D. Shire Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals Eur J Pharmacol 339 1997 53 61
39. G. Griffin, Q. Tao, and M.E. Abood Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor J Pharmacol Exp Ther 292 2000 886 894
40. N. Hájos, and T.F. Freund Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers Neuropharmacology 43 2002 503 510
41. N. Hájos, I. Katona, S.S. Naiem, K. MacKie, C. Ledent, and I. Mody Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations Eur J Neurosci 12 2000 3239 3249
42. N. Hájos, C. Ledent, and T.F. Freund Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus Neuroscience 106 2001 1 4
43. J. Haller, N. Bakos, M. Szirmay, C. Ledent, and T.F. Freund The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety Eur J Neurosci 16 2002 1395 1398
44. J. Haller, B. Varga, C. Ledent, and T.F. Freund CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents Behav Pharmacol 15 2004 299 304
45. A.J. Hampson, M. Grimaldi, J. Axelrod, and D. Wink Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroptotective antioxidants Proc Natl Acad Sci U S A 95 1998 8268 8273
46. L. Hanus, S. Abu-Lafi, E. Fride, A. Breuer, Z. Vogel, and D.E. Shalev 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor Proc Natl Acad Sci U S A 98 2001 3662 3665
47. L. Hanus, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, and M. Horowitz HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor Proc Natl Acad Sci U S A 96 1999 14228 14233
48. D. Harris, A.I. McCulloch, D.A. Kendall, and M.D. Randall Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed J Physiol 539 2002 893 902
49. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, and B.R. De Costa Cannabinoid receptor localization in brain Proc Natl Acad Sci U S A 87 1990 1932 1936
50. C.J. Hillard, S. Manna, M.J. Greenberg, R. DiCamelli, R.A. Ross, and L.A. Stevenson Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1) J Pharmacol Exp Ther 289 1999 1427 1433
51. W.S. Ho, and C.R. Hiley Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery Br J Pharmacol 138 2003 1320 1332
52. W.S. Ho, and C.R. Hiley Vasorelaxanat activities of the putative endocannabinoid virodhamine in rat isolated mesenteric artery J Pharm Pharmacol 56 2004 869 875
53. D.B. Houston, and A.C. Howlett Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists Cell Signal 10 1998 667 674
54. A.C. Howlett Efficacy in CB1 receptor-mediated signal transduction Br J Pharmacol 142 2004 1209 1218
55. S.M. Huang, T. Bisogno, M. Trevisani, A. Al-Hayani, L. De Petrocellis, and M. Fezza An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors Proc Natl Acad Sci U S A 99 2002 8400 8405
56. J.W. Huffman, J. Liddle, S. Yu, M.M. Aung, M.E. Abood, and J.L. Wiley 3-(1′,1′-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor Bioorg Med Chem 7 1999 2905 2914
57. 1 receptors on peripheral sympathetic nerves Br J Pharmacol 118 1996 2023 2028
58. 2+-induced relaxation J Pharmacol Exp Ther 289 1999 245 250
59. Z. Járai, J.A. Wagner, K. Varga, K.D. Lake, D.R. Compton, and B.R. Martin Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Proc Natl Acad Sci U S A 96 1999 14136 14141
60. K. Kapoor, U. Arulmani, J.P. Heiligers, I.M. Garrelds, E.W. Willems, and H. Doods Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs Br J Pharmacol 140 2003 329 338
61. S. Kathuria, S. Gaetani, D. Fegley, F. Valino, A. Duranti, and A. Tontini Modulation of anxiety through blockade of anandamide hydrolysis Nat Med 9 2003 76 81
62. C.S. Kearn, M.J. Greenberg, R. DiCamelli, K. Kurzawa, and C.J. Hillard Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange J Neurochem 72 1999 2379 2387
63. A.C. Kreitzer, and W.G. Regehr Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells Neuron 29 2001 717 727
64. C. Ledent, O. Valverde, G. Cossu, F. Petitet, J.F. Aubert, and F. Beslot Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice Science 283 1999 401 404
65. H. Lim, and S.K. Dey A novel pathway of prostacyclin signaling-hanging out with nuclear receptors Endocrinology 143 2002 3207 3210
66. J. Liu, S. Bátkai, P. Pacher, J. Harvey-White, J.A. Wagner, and B.F. Cravatt Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-κB independently of platelet-activating factor J Biol Chem 278 2003 45034 45039
67. J. Liu, B. Gao, F. Mirshahi, A.J. Sanyal, A.D. Khanolkar, and A. Makriyannis Functional CB1 cannabinoid receptors in human vascular endothelial cells Biochem J 346 2000 835 840
68. A. Losonczy, A.A. Biro, and Z. Nusser Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons Proc Natl Acad Sci U S A 101 2004 1362 1367
69. B. Lutz Molecular biology of cannabinoid receptors Prostaglandins Leukot Essent Fat Acids 66 2002 123 142
70. K. Mackie, and B. Hille Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells Proc Natl Acad Sci U S A 89 1992 3825 3829
71. K. Mackie, Y. Lai, R. Westenbroek, and R. Mitchell Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor J Neurosci 15 1995 6552 6561
72. T.P. Malan Jr., M.M. Ibrahim, H. Deng, Q. Liu, H.P. Mata, and T. Vanderah CB2 cannabinoid receptor-mediated peripheral antinociception Pain 93 2001 239 245
73. B. Malinowska, G. Kwolek, and M. Gothert Anandamide and methanandamide induce both vanilloid VR1- and cannabinoids CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats Naunyn Schmiedebergs Arch Pharmacol 364 2001 562 569
74. C.F. Mang, D. Erbelding, and H. Kilbinger Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors Br J Pharmacol 134 2001 161 167
75. S. Marinelli, V. Di Marzo, N. Berretta, I. Matias, M. Maccarrone, and G. Bernardi Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors J Neurosci 23 2003 3136 3144
76. S. Mato, A. Pazos, and E.M. Valdizan Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain Eur J Pharmacol 443 2002 43 46
77. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
78. D.S. McQueen, S.M. Bond, P.J.W. Smith, K. Balali-Mood, and D. Smart Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats Eur J Pharmacol 491 2004 181 189
79. R. Mechoulam, S. Benshabat, L. Hanus, M. Ligumsky, N.E. Kaminski, and A.R. Schatz Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 1995 83 90
80. J.P. Meschler, D.M. Kraichely, G.H. Wilken, and A.C. Howlett Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor Biochem Pharmacol 60 2000 1315 1323
81. E. Mezey, Z.E. Toth, D.N. Cortright, M.K. Arzubi, J.E. Krause, and R. Elde Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human Proc Nat Acad Sci U S A 97 2000 3655 3660
82. D.L. Misner, and J.M. Sullivan Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons J Neurosci 19 1999 6795 6805
83. F.M. Mo, L. Offertáler, and G. Kunos Atypical cannabinoid stimulates endothelial cell migration via Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1 Eur J Pharmacol 489 2004 21 27
84. S. Mukhopadhyay, B.M. Chapnick, and A.C. Howlett Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent Am J Physiol 282 2002 H2046 H2054
85. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
86. L. Offertáler, F.M. Mo, S. Bátkai, J. Liu, M. Begg, and R.K. Razdan Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor Mol Pharmacol 63 2003 699 705
87. T. Ohno-Shosaku, H. Tsubokawa, I. Mizushima, N. Yoneda, A. Zimmer, and M. Kano Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses J Neurosci 22 2002 3864 3872
88. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA) Br J Pharmacol 141 2004 803 812
89. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries Br J Pharmacol 142 2004 435 442
90. P. Pacher, S. Bátkai, and G. Kunos Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice J Physiol (Lond) 558 2004 647 657
91. 2+ currents by reversal of tonic CB1 cannabinoid receptor activity Mol Pharmacol 54 1998 1064 7102
92. R.G. Pertwee Pharmacology of cannabinoid CB1 and CB2 receptors Pharmacol Ther 74 1997 129 180
93. R.G. Pertwee Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors Life Sci 65 1999 597 605
94. M. Pistis, S. Perra, G. Pillolla, M. Melis, G.L. Gessa, and A.L. Muntoni Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions Neuropharmacology 46 2004 115 125
95. A.C. Porter, J.M. Sauer, M.D. Knierman, G.W. Becker, M.J. Berna, and J. Bao Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J Pharmacol Exp Ther 301 2002 1020 1024
96. V. Ralevic, D.A. Kendall, M.D. Randall, and D. Smart Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function Life Sci 71 2002 2577 2594
97. V. Ralevic, D.A. Kendall, M.D. Randall, P.M. Zygmunt, P. Movahed, and E.D. Hogestatt Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries Br J Pharmacol 130 2000 1483 1488
98. M.D. Randall, and D.A. Kendall Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery Eur J Pharmacol 346 1998 51 53
99. P.H. Reggio Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors Curr Pharm Res 9 2003 1607 1633
100. M. Rinaldi-Carmona, F. Barth, M. Heaulme, D. Shire, B. Calandra, and C. Congy SR141716A, a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett 350 1994 240 244
101. M. Rinaldi-Carmona, F. Barth, J. Millan, J.M. Derocq, P. Casellas, and C. Congy SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor J Pharmacol Exp Ther 284 1998 644 650
102. N. Rouach, and R.A. Nicoll Endocannabinoids contribute to short-term but not long-term mGluR-induced depression in the hippocampus Eur J Neurosci 18 2003 1017 1020
103. D. Rueda, I. Galve-Roperh, A. Haro, and M. Guzman The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase Mol Pharmacol 58 2000 814 820
104. D. Shire, B. Calandra, M. Rinaldi-Carmona, D. Oustric, B. Pessegue, and O. Bonnin-Cabanne Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor Biochim Biophys Acta 1307 1996 132 136
105. D. Shire, C. Carillon, M. Kaghad, B. Calandra, M. Rinaldi-Carmona, and G. Le Fur An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing J Biol Chem 270 1996 3726 3731
106. V.M. Showalter, D.R. Compton, B.R. Martin, and M.E. Abood Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands J Pharmacol Exp Ther 278 1996 989 999
107. D. Smart, M.J. Gunthorpe, J.C. Jerman, S. Nasir, J. Gray, and A.I. Muir The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) Br J Pharmacol 129 2000 227 230
108. P.J. Smith, and D.S. McQueen Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized rat Br J Pharmacol 134 3 2001 655 663
109. N. Stella, P. Schweitzer, and D. Piomelli A second endogenous cannabinoid that modulates long-term potentiation Nature 388 1997 773 778
110. T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, and K. Itoh 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem Biophys Res Commun 215 1995 89 97
111. J. Szolcsányi Are cannabinoids endogenous ligands for the VR1 capsaicin receptor? Trends Pharmacol Sci 21 2000 41 42
112. K. Varga, K. Lake, B.R. Martin, and G. Kunos G Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide Eur J Pharmacol 278 1995 279 283
113. K. Varga, J.A. Wagner, D.T. Bridgen, and G. Kunos Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension FASEB J 12 1998 1035 1044
114. J.A. Wagner, K. Hu, J. Bauersachs, J. Karcher, M. Wiesler, and S.K. Goparaju Endogenous cannabinoids mediate hypotension after experimental myocardial infarction J Am Coll Cardiol 38 2001 2048 2054
115. J.A. Wagner, Z. Járai, S. Bátkai, and G. Kunos Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors Eur J Pharmacol 423 2001 203 210
116. J.A. Wagner, K. Varga, Z. Járai, and G. Kunos Mesenteric vasodilation mediated by endothelial anandamide receptors Hypertension 33 1999 429 434
117. L. Walter, A. Franklin, A. Witting, C. Wade, Y. Xie, and G. Kunos Nonpsychotropic cannabinoid receptors regulate microglial cell migration J Neurosci 23 2003 1398 1405
118. 4 channels Nature 424 2003 434 438
119. R. White, and C.R. Hiley A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery Br J Pharmacol 122 1997 1573 1584
120. R. White, W.S. Ho, F.E. Bottrill, W.R. Ford, and C.R. Hiley Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries Br J Pharmacol 134 2001 921 929
121. R.I. Wilson, and R.A. Nicoll Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses Nature 410 2001 588 592
122. R.I. Wilson, G. Kunos, and R.A. Nicoll Presynaptic specificity of endocannabinoid signalling in the hippocampus Neuron 31 2001 453 462
123. M.R. Zahner, D.P. Li, S.R. Chen, and H.L. Pan Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats J Physiol (Lond) 551 2003 515 523
124. A. Zimmer, A.M. Zimmer, A.G. Hohmann, M. Herkenham, and T.I. Bonner Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice Proc Natl Acad Sci U S A 96 1999 5780 5785
125. P.M. Zygmunt, D.A. Andersson, and E.D. Högestätt Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism J Neurosci 22 2002 4720 4727
126. P.M. Zygmunt, J. Petersson, D.A. Andersson, H.-H. Chuang, M. Sorgard, and V. Di Marzo Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457